Cita APA

Lakeman, I., van den Broek, A. J., Vos, J. A. M., Barnes, D., Adlard, J., andrulis, i., & Balmaña, J. (2021). The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Citación estilo Chicago

Lakeman, Inge, Alexandra J. van den Broek, Juliën A. M. Vos, Daniel Barnes, Julian Adlard, irene andrulis, y Judith Balmaña. The Predictive Ability of the 313 Variant–based Polygenic Risk Score for Contralateral Breast Cancer Risk Prediction in Women of European Ancestry With a Heterozygous BRCA1 or BRCA2 Pathogenic Variant. 2021.

Cita MLA

Lakeman, Inge, et al. The Predictive Ability of the 313 Variant–based Polygenic Risk Score for Contralateral Breast Cancer Risk Prediction in Women of European Ancestry With a Heterozygous BRCA1 or BRCA2 Pathogenic Variant. 2021.